In vitro characterization of pluronic F127 and D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles as nanocarriers for targeted anticancer-drug delivery

Journal of Nanomaterials

Volumn 2012, Issue , 2012, Pages

  Butt, Adeel Masood ^a   Amin, Mohd Cairul Iqbal Mohd ^a   Katas, Haliza ^a   Sarisuta, Narong ^b   Witoonsaridsilp, Wasu ^b   Benjakul, Ruthairat ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER DRUG; APOPTOSIS ACTIVITY; CELL LINES; CHEMOTHERAPEUTIC AGENTS; DOXORUBICIN; DRUG LOADING; DRUG RELEASE; ENTRAPMENT EFFICIENCY; HUMAN BREAST; IN-VITRO; MIXED MICELLES; MOLAR RATIO; NANOCARRIERS; PHYSIOLOGICAL PH; PLURONIC F-127; TARGETED DELIVERY; TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATES;

BODY FLUIDS; CELL CULTURE; CELL DEATH; CRITICAL MICELLE CONCENTRATION; DRUG DELIVERY; LOADING; PH; POLYETHYLENE GLYCOLS; ZETA POTENTIAL;

MICELLES;

EID: 84867862850     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2012/916573     Document Type: Article

References (35)

1. Laengler A., Spix C., Seifert G., Gottschling S., Graf N., Kaatsch P., Complementary and alternative treatment methods in children with cancer: a population-based retrospective survey on the prevalence of use in Germany. European Journal of Cancer 2008 44 15 2233 2240 2-s2.0-53349177761 10.1016/j.ejca.2008.07.020
2. Brigger I., Dubernet C., Couvreur P., Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews 2002 54 5 631 651 2-s2.0-0037072566 10.1016/S0169-409X(02)00044-3
3. Feng S. S., Zhao L., Zhang Z., Bhakta G., Yin Win K., Dong Y., Chien S., Chemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo. Chemical Engineering Science 2007 62 23 6641 6648 2-s2.0-35349017895 10.1016/j.ces.2007.08.006
4. Primeau A. J., Rendon A., Hedley D., Lilge L., Tannock I. F., The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clinical Cancer Research 2005 11 24 8782 8788 2-s2.0-29344443251 10.1158/1078-0432.CCR-05-1664
5. Hatefi A., Amsden B., Camptothecin delivery methods. Pharmaceutical Research 2002 19 10 1389 1399 2-s2.0-0036803284 10.1023/A:1020427227285
6. Williams J., Lansdown R., Sweitzer R., Romanowski M., LaBell R., Ramaswami R., Unger E., Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. Journal of Controlled Release 2003 91 1-2 167 172 2-s2.0-0141955909 10.1016/S0168-3659(03)00241-4
7. Patel N. R., Rathi A., Mongayt D., Torchilin V. P., Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes. International Journal of Pharmaceutics 2011 416 1 296 299 2-s2.0-79959654405 10.1016/j.ijpharm.2011.05.082
8. Li X., Ding L., Xu Y., Wang Y., Ping Q., Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. International Journal of Pharmaceutics 2009 373 1-2 116 123 2-s2.0-67349233077 10.1016/j.ijpharm.2009.01. 023
9. Letchford K., Burt H., A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. European Journal of Pharmaceutics and Biopharmaceutics 2007 65 3 259 269 2-s2.0-33847256524 10.1016/j.ejpb.2006.11.009
10. Hu Y., Ding Y., Ding D., Sun M., Zhang L., Jiang X., Yang C., Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers. Biomacromolecules 2007 8 4 1069 1076 2-s2.0-34247562691 10.1021/bm0608176
11. Tong R., Cheng J., Anticancer polymeric nanomedicines. Polymer Reviews 2007 47 3 345 381 2-s2.0-34547797860 10.1080/15583720701455079
12. Torchilin V. P., Structure and design of polymeric surfactant-based drug delivery systems. Journal of Controlled Release 2001 73 2-3 137 172 2-s2.0-0035850224 10.1016/S0168-3659(01)00299-1
13. Torchilin V. P., Micellar nanocarriers: pharmaceutical perspectives. Pharmaceutical Research 2007 24 1 1 16 2-s2.0-33845388144 10.1007/s11095-006- 9132-0
14. Kataoka K., Harada A., Nagasaki Y., Block copolymer micelles for drug delivery: design, characterization and biological significance. Advanced Drug Delivery Reviews 2001 47 1 113 131 2-s2.0-0035937592 10.1016/S0169-409X(00) 00124-1
15. Mu L., Elbayoumi T. A., Torchilin V. P., Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and D- α -tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. International Journal of Pharmaceutics 2005 306 1-2 142 149 2-s2.0-27844496561 10.1016/j.ijpharm.2005.08.026
16. Matsumura Y., Hamaguchi T., Ura T., Muro K., Yamada Y., Shimada Y., Shirao K., Okusaka T., Ueno H., Ikeda M., Watanabe N., Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. British Journal of Cancer 2004 91 10 1775 1781 2-s2.0-10844293438 10.1038/sj.bjc.6602204
17. Plummer R., Wilson R. H., Calvert H., Boddy A. V., Griffin M., Sludden J., Tilby M. J., Eatock M., Pearson D. G., Ottley C. J., Matsumura Y., Kataoka K., Nishiya T., A phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. British Journal of Cancer 2011 104 4 593 598 2-s2.0-79951682119 10.1038/bjc.2011.6
18. Hamaguchi T., Kato K., Yasui H., Morizane C., Ikeda M., Ueno H., Muro K., Yamada Y., Okusaka T., Shirao K., Shimada Y., Nakahama H., Matsumura Y., A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. British Journal of Cancer 2007 97 2 170 176 2-s2.0-34447331464 10.1038/sj.bjc.6603855
19. Zhang W., Shi Y., Chen Y., Yu S., Hao J., Luo J., Sha X., Fang X., Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. European Journal of Pharmaceutics and Biopharmaceutics 2010 75 3 341 353 2-s2.0-77954535848 10.1016/j.ejpb.2010.04.017
20. Alakhov V., Kabanov A., Chiellini E., Sunamoto J., Migliaresi C., Ottenbrite R. M., Cohn D., Block copolymer-based formulations of doxorubicin efective against drug resistant tumours. Biomedical Polymers and Polymer Therapeutics 2002 New York, NY, USA Kluwer Academic 121 137
21. Kabanov A. V., Batrakova E. V., Alakhov V. Y., Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. Journal of Controlled Release 2002 82 2-3 189 212 2-s2.0-0037151313 10.1016/S0168-3659(02)00009-3
22. Alakhov V. Y., Moskaleva E. Y., Batrakova E. V., Kabanov A. V., Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjugate Chemistry 1996 7 2 209 216 2-s2.0-0030111359
23. Batrakova E. V., Li S., Brynskikh A. M., Sharma A. K., Li Y., Boska M., Gong N., Mosley R. L., Alakhov V. Y., Gendelman H. E., Kabanov A. V., Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. Journal of Controlled Release 2010 143 3 290 301 2-s2.0-77952242570 10.1016/j.jconrel.2010.01.004
24. Batrakova E. V., Li S., Elmquist W. F., Miller D. W., Alakhov V. Y., Kabanov A. V., Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: selective energy depletion. British Journal of Cancer 2001 85 12 1987 1997 2-s2.0-0035556313
25. Li L. B., Tan Y. B., Preparation and properties of mixed micelles made of pluronic polymer and PEG-PE. Journal of Colloid and Interface Science 2008 317 1 326 331 2-s2.0-36049026548 10.1016/j.jcis.2007.09.053
26. Gao Y., Li L. B., Zhai G., Preparation and characterization of pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids and Surfaces B 2008 64 2 194 199 2-s2.0-43849099717 10.1016/j.colsurfb.2008.01.021
27. Youk H. J., Lee E., Choi M. K., Lee Y. J., Chung J. H., Kim S. H., Lee C. H., Lim S. J., Enhanced anticancer efficacy of α -tocopheryl succinate by conjugation with polyethylene glycol. Journal of Controlled Release 2005 107 1 43 52 2-s2.0-24344456703 10.1016/j.jconrel.2005.05.014
28. Wang C. H., Wang C. H., Hsiue G. H., Polymeric micelles with a pH-responsive structure as intracellular drug carriers. Journal of Controlled Release 2005 108 1 140 149 2-s2.0-26944492164 10.1016/j.jconrel.2005.07.017
29. Tan H., Zhang Y., Wang M., Zhang Z., Zhang X., Yong A. M., Wong S. Y., Chang A. Y. C., Chen Z. K., Li X., Choolani M., Wang J., Silica-shell cross-linked micelles encapsulating fluorescent conjugated polymers for targeted cellular imaging. Biomaterials 2012 33 1 237 246 10.1016/j.biomaterials.2011. 09.037
30. Gao Z. G., Fain H. D., Rapoport N., Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. Journal of Controlled Release 2005 102 1 203 222 2-s2.0-11844266507 10.1016/j.jconrel.2004.09.021
31. Torchilin V. P., PEG-based micelles as carriers of contrast agents for different imaging modalities. Advanced Drug Delivery Reviews 2002 54 2 235 252 2-s2.0-0037148667 10.1016/S0169-409X(02)00019-4
32. Hu H., Yu J., Li Y., Zhao J., Dong H., Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. Journal of Biomedical Materials Research Part A 2012 100 1 141 148
33. Zhang W., Shi Y., Chen Y., Hao J., Sha X., Fang X., The potential of pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials 2011 32 25 5934 5944 2-s2.0-79957902948 10.1016/j.biomaterials.2011.04.075
34. Gaucher G., Dufresne M. H., Sant V. P., Kang N., Maysinger D., Leroux J. C., Block copolymer micelles: preparation, characterization and application in drug delivery. Journal of Controlled Release 2005 109 13 169 188 2-s2.0-28544450961 10.1016/j.jconrel.2005.09.034
35. Chandrasekharan P., Maity D., Yong C. X., Chuang K. H., Ding J., Feng S. S., Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles-superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI. Biomaterials 2011 32 24 5663 5672 2-s2.0-79957958314 10.1016/j.biomaterials.2011.04.037